AI tool for diagnosing breast phyllodes tumors
Part of Cancer clinical trials.
This trial uses an artificial intelligence system to help doctors more accurately diagnose and predict the outcome of breast phyllodes tumors, which are rare breast growths. It aims to improve how these tumors are identified and managed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with a phyllodes tumor of the breast.
- Your medical images (like ultrasound or mammogram) are clear and not blurry or distorted.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether an artificial intelligence (AI) tool can help doctors plan radiation therapy more precisely for breast cancer. It aims to make treatment safer and more effective by using AI to outline the area to be treated.
This study tests an artificial intelligence (AI) system that uses your health information and medical images to better judge cancer risk and support diagnosis and treatment decisions. It may help doctors make more consistent assessments by combining clinical records, imaging, and other lab-style data.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This study tests a new artificial intelligence (AI) tool that works with doctors to more accurately diagnose breast cancer that has a large area of early-stage cells (DCIS) mixed with invasive cancer. It may help improve treatment decisions for people with larger, calcified tumors.
This trial is testing an artificial intelligence system that helps doctors diagnose ovarian tumors more accurately using imaging and blood tests. It may lead to better treatment decisions for patients.
This trial uses artificial intelligence (AI) to help doctors more accurately identify early-stage breast cancer from test results. It could lead to faster and more precise diagnosis, which may help you get the right treatment sooner.
Hear when a new Multiomics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.